Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Zymeworks, Janssen in $1.45B Antibody Licensing Deal

Janssen Biotech, a division of drug maker Johnson & Johnson, is acquiring technologies that make it possible to create synthetic antibodies that hit multiple targets. . . . → Read More: Zymeworks, Janssen in $1.45B Antibody Licensing Deal

Math Models to Predict Animal-Borne Disease Outbreaks

A team of ecologists and mathematicians is applying machine learning and statistical models to forecast outbreaks of zoonotic diseases, those spread to humans from animals. . . . → Read More: Math Models to Predict Animal-Borne Disease Outbreaks

Sanofi Acquires Multiple Sclerosis Drug in $800M Deal

Drug maker Sanofi is licensing a drug candidate from Principia Biopharma Inc. designed to treat multiple sclerosis, an autoimmune condition affecting the brain and nervous system. . . . → Read More: Sanofi Acquires Multiple Sclerosis Drug in $800M Deal

Cancer Center, Analytics Company Partner on Precision Care

Memorial Sloan Kettering Cancer Center in New York is collaborating with health care analytics company Cota Inc. to offer more precise care strategies for patients. . . . → Read More: Cancer Center, Analytics Company Partner on Precision Care

Open-Source Model Devised to Value Medical Technologies

An initiative joining most major health care stakeholders is developing models to calculate the value of medical treatments, with a process described as open and transparent. . . . → Read More: Open-Source Model Devised to Value Medical Technologies

New Finance, Development Model for Pancreatic Disease

An organization is being formed to adopt performance-based financing and precision medicine to accelerate research and development on pancreatitis. . . . → Read More: New Finance, Development Model for Pancreatic Disease

New Drug Shown to Reduce Depressive Behaviors

A new type of treatment for depression that works differently from most other anti-depressive drugs was shown in lab mice to reduce depression-like behaviors. . . . → Read More: New Drug Shown to Reduce Depressive Behaviors

FDA Sets Genetic Health Test Review Process

The U.S. Food and Drug Administration is proposing new review requirements for genetic tests of health risks that providers market directly to consumers. . . . → Read More: FDA Sets Genetic Health Test Review Process

Plasma Infusions to Treat Alzheimer’s Shown Safe

Results from a small-scale clinical trial indicate treatments with plasma infusions from young donors are safe for patients and may improve functional abilities. . . . → Read More: Plasma Infusions to Treat Alzheimer’s Shown Safe

Start-Up Formed to Develop Non-Opioid Pain Drugs

A new enterprise is being formed to develop non-addictive drugs for chronic pain that use different biochemical processes than opioid pain relievers. . . . → Read More: Start-Up Formed to Develop Non-Opioid Pain Drugs